Regression of oxidative stress by targeting Nrf2/HO-1 signaling: The potential therapeutic drugs for cerebral ischemia-reperfusion injury
Authors:
Open Access
- 22 November 2025
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 193, 118809
Abstract
No abstract availableKeywords
Funding Information
- Shaanxi Administration of Traditional Chinese Medicine (ZYJXG-L23001)
- Key Research and Development Projects of Shaanxi Province (2024SF-ZDCYL-03-16)
This publication has 127 references indexed in Scilit:
- Epicatechin‐mediated modulation of the Nrf2/HO‐1 pathway alleviates senile cerebral ischemic/reperfusion injuryFood Science & Nutrition, 2024
- Effects and safety of resveratrol supplementation in older adults: A comprehensive systematic reviewPhytotherapy Research, 2024
- 20(R)‐ginsenoside Rg3 attenuates cerebral ischemia–reperfusion injury by mitigating mitochondrial oxidative stress via the Nrf2/HO‐1 signaling pathwayPhytotherapy Research, 2024
- Drugs/agents for the treatment of ischemic stroke: Advances and perspectivesMedicinal Research Reviews, 2023
- Trilobatin promotes angiogenesis after cerebral ischemia–reperfusion injury via SIRT7/VEGFA signaling pathway in ratsPhytotherapy Research, 2022
- Subacute 28 days oral toxicity study of kaempferol and biochanin‐A in the mouse modelJournal of Biochemical and Molecular Toxicology, 2022
- Developmental toxicity, antioxidant, and marker enzyme assessment of swertiamarin in zebrafish (Danio rerio)Journal of Biochemical and Molecular Toxicology, 2021
- Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO‐1 signaling pathwayBrain and Behavior, 2021
- Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implicationsMedicinal Research Reviews, 2021
- Genistein attenuates ischemic oxidative damage and behavioral deficits via eNOS/Nrf2/HO-1 signalingHippocampus, 2013